Abstract
Samarium-153-EDTMP (ethylene diamine tetramethylene phosphonate), for its promising biological properties, has been proved as a palliating therapeutic agent for boné cancer in human beings. In this article, we present the results on synthesis and structure analysis of Samarium-153-EDTMP. In a basic medium,153Sm-EDTMP can be readily prepared with a complexing yield not less than 98%, and it is confirmed that the ratio of the ligand to Sm is 1∶1, and the charge of153Sm-EDTMP is negative two.
Similar content being viewed by others
References
D. P. JOSHI et al., JAMA, 193 (1965) 621.
E. KAPLAN et al., J. Nucl. Med., 1 (1960) 1.
M. S. POTSAID et al., J. Nucl. Med., 19 (1978) 98.
J. H. LAWRENCE et al., Ann. Intern. Med., 33 (1950) 41.
E. B. SILBERSTEIN, et al., J. Nucl. Med., 26 (1985) 345.
E. K. REDDY et al., J. Natl. Med. Assoc., 78 (1986) 27.
M. EISENHUT et al., J. Nucl. Med. 27 (1986) 1255.
W. E. GOECKELAR et al., Nucl. Med. Biol., 13 (1986) 479.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luo, S.Z., Pu, M.F., Quao, J. et al. A potential bone tumor therapeutic agent153Sm-EDTMP: Its synthesis and preliminary structure analysis. Journal of Radioanalytical and Nuclear Chemistry, Articles 160, 443–448 (1992). https://doi.org/10.1007/BF02037119
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02037119